chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Tenderness
Clinical narrative: arm tender; not being able to sleep well; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (arm tender) and INSOMNIA (not being able to sleep well) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced TENDERNESS (arm tender) and INSOMNIA (not being able to sleep well). On 27-Jan-2021, TENDERNESS (arm tender) and INSOMNIA (not being able to sleep well) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.     This case was linked to MOD-2021-309642 (Patient Link).
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: did not get second dose in the time period stipulated for the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (did not get second dose in the time period stipulated for the second dose) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (did not get second dose in the time period stipulated for the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (did not get second dose in the time period stipulated for the second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported. No treatment information was provided by the reporter.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Palpitations, Product dose omission issue, Vaccination complication
Clinical narrative: bad reaction to my first dose of the vaccine; didn't take her second dose; lost the feeling in her hand and feet; heart palpitations; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (lost the feeling in her hand and feet), PALPITATIONS (heart palpitations), VACCINATION COMPLICATION (bad reaction to my first dose of the vaccine) and PRODUCT DOSE OMISSION ISSUE (didn't take her second dose) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced PALPITATIONS (heart palpitations). On 08-Apr-2021, the patient experienced HYPOAESTHESIA (lost the feeling in her hand and feet). On an unknown date, the patient experienced VACCINATION COMPLICATION (bad reaction to my first dose of the vaccine) and PRODUCT DOSE OMISSION ISSUE (didn't take her second dose). The patient was treated with VITAMIN B12 [VITAMIN B12 NOS] ongoing since an unknown date for Hypoaesthesia, at a dose of 1 dosage form. On 20-Apr-2021, PALPITATIONS (heart palpitations) had resolved. At the time of the report, HYPOAESTHESIA (lost the feeling in her hand and feet), VACCINATION COMPLICATION (bad reaction to my first dose of the vaccine) and PRODUCT DOSE OMISSION ISSUE (didn't take her second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Sep-2021: Significant follow-up received on 06 Sep 2021: Added new event
Sex: U
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: Full body muscle cramps for the last two hours; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Full body muscle cramps for the last two hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Full body muscle cramps for the last two hours). At the time of the report, MUSCLE SPASMS (Full body muscle cramps for the last two hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment information was not provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: IIIrd nerve paralysis, Sinusitis
Clinical narrative: 2 weeks later he was diagnosed from 3rd cranial nerve palsy; sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of IIIRD NERVE PARALYSIS (2 weeks later he was diagnosed from 3rd cranial nerve palsy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IIIRD NERVE PARALYSIS (2 weeks later he was diagnosed from 3rd cranial nerve palsy) (seriousness criterion medically significant) and SINUSITIS (sinus infection). At the time of the report, IIIRD NERVE PARALYSIS (2 weeks later he was diagnosed from 3rd cranial nerve palsy) and SINUSITIS (sinus infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.  Company Comment:  Very limited information regarding this event/s has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time. Further information has been requested.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: tingling in their left hand / tingling mostly in their left pinky; numbness in their left hand/ numbness mostly in their left pinky; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in their left hand / tingling mostly in their left pinky) and HYPOAESTHESIA (numbness in their left hand/ numbness mostly in their left pinky) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Sep-2021, the patient experienced PARAESTHESIA (tingling in their left hand / tingling mostly in their left pinky) and HYPOAESTHESIA (numbness in their left hand/ numbness mostly in their left pinky). At the time of the report, PARAESTHESIA (tingling in their left hand / tingling mostly in their left pinky) and HYPOAESTHESIA (numbness in their left hand/ numbness mostly in their left pinky) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The treatment history was not reported. The concomitant medication was not reported.
Sex: U
Vaccine: COVID19
Symptoms: Bursitis, Pain, Tendonitis
Clinical narrative: Tendanitis; Bursitis; In bad pain; This spontaneous case was reported by a consumer and describes the occurrence of TENDONITIS (Tendanitis), BURSITIS (Bursitis) and PAIN (In bad pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TENDONITIS (Tendanitis), BURSITIS (Bursitis) and PAIN (In bad pain). At the time of the report, TENDONITIS (Tendanitis), BURSITIS (Bursitis) and PAIN (In bad pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product use was provided by the reporter. No treatment medication was provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Asthenia, Intervertebral disc disorder, Magnetic resonance imaging
Clinical narrative: Inflammation between her vertebrae; Stenosis; Arthritis; Flattening of the nerve; Weakness; Pain on fingers/Pain on arms; she had pain on her upper body (arms, shoulders, fingers); needle like feeling on her fingers,; ice coldness feeling on her fingers; Pain on shoulders; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis) and NERVE COMPRESSION (Flattening of the nerve) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hashimoto's disease, Penicillin allergy (Penicillin or any other penicillin derivatives) and Arthritis. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), LAMOTRIGINE (LAMICTAL), CALCIUM, VITAMIN C [ASCORBIC ACID], ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]) and BIOTIN for an unknown indication.    On 24-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2021, the patient experienced ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis), NERVE COMPRESSION (Flattening of the nerve), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain on fingers/Pain on arms), PAIN (she had pain on her upper body (arms, shoulders, fingers)), PARAESTHESIA (needle like feeling on her fingers,) and PERIPHERAL COLDNESS (ice coldness feeling on her fingers). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 6 Tab once a day and LORAZEPAM (ATIVAN) at a dose of 1 Tab once a day. At the time of the report, ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis), NERVE COMPRESSION (Flattening of the nerve), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain on fingers/Pain on arms), PAIN (she had pain on her upper body (arms, shoulders, fingers)), PARAESTHESIA (needle like feeling on her fingers,) and PERIPHERAL COLDNESS (ice coldness feeling on her fingers) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: abnormal (abnormal) inflammation between vertebrae (C1 to C7 and T2 to T3), stenosis.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient is allergic to latex, fragrance, aromatic soaps, detergents, furr,. fruits like mangoes and kiwi. Also had high ANA levels and considered to be immunocompromised.   This case was linked to MOD-2021-309590.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Nerve compression, Pain, Pain in extremity, Paraesthesia, Peripheral coldness
Clinical narrative: Inflammation between her vertebrae; Stenosis; Arthritis; Flattening of the nerve; Weakness; Pain on fingers/Pain on arms; she had pain on her upper body (arms, shoulders, fingers); needle like feeling on her fingers,; ice coldness feeling on her fingers; Pain on shoulders; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis) and NERVE COMPRESSION (Flattening of the nerve) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hashimoto's disease, Penicillin allergy (Penicillin or any other penicillin derivatives) and Arthritis. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), LAMOTRIGINE (LAMICTAL), CALCIUM, VITAMIN C [ASCORBIC ACID], ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]) and BIOTIN for an unknown indication.    On 24-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2021, the patient experienced ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis), NERVE COMPRESSION (Flattening of the nerve), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain on fingers/Pain on arms), PAIN (she had pain on her upper body (arms, shoulders, fingers)), PARAESTHESIA (needle like feeling on her fingers,) and PERIPHERAL COLDNESS (ice coldness feeling on her fingers). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 6 Tab once a day and LORAZEPAM (ATIVAN) at a dose of 1 Tab once a day. At the time of the report, ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis), NERVE COMPRESSION (Flattening of the nerve), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain on fingers/Pain on arms), PAIN (she had pain on her upper body (arms, shoulders, fingers)), PARAESTHESIA (needle like feeling on her fingers,) and PERIPHERAL COLDNESS (ice coldness feeling on her fingers) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: abnormal (abnormal) inflammation between vertebrae (C1 to C7 and T2 to T3), stenosis.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient is allergic to latex, fragrance, aromatic soaps, detergents, furr,. fruits like mangoes and kiwi. Also had high ANA levels and considered to be immunocompromised.   This case was linked to MOD-2021-309590.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Stenosis
Clinical narrative: Inflammation between her vertebrae; Stenosis; Arthritis; Flattening of the nerve; Weakness; Pain on fingers/Pain on arms; she had pain on her upper body (arms, shoulders, fingers); needle like feeling on her fingers,; ice coldness feeling on her fingers; Pain on shoulders; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis) and NERVE COMPRESSION (Flattening of the nerve) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hashimoto's disease, Penicillin allergy (Penicillin or any other penicillin derivatives) and Arthritis. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), LAMOTRIGINE (LAMICTAL), CALCIUM, VITAMIN C [ASCORBIC ACID], ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]) and BIOTIN for an unknown indication.    On 24-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Aug-2021, the patient experienced ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis), NERVE COMPRESSION (Flattening of the nerve), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain on fingers/Pain on arms), PAIN (she had pain on her upper body (arms, shoulders, fingers)), PARAESTHESIA (needle like feeling on her fingers,) and PERIPHERAL COLDNESS (ice coldness feeling on her fingers). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 6 Tab once a day and LORAZEPAM (ATIVAN) at a dose of 1 Tab once a day. At the time of the report, ARTHRALGIA (Pain on shoulders), INTERVERTEBRAL DISC DISORDER (Inflammation between her vertebrae), STENOSIS (Stenosis), ARTHRITIS (Arthritis), NERVE COMPRESSION (Flattening of the nerve), ASTHENIA (Weakness), PAIN IN EXTREMITY (Pain on fingers/Pain on arms), PAIN (she had pain on her upper body (arms, shoulders, fingers)), PARAESTHESIA (needle like feeling on her fingers,) and PERIPHERAL COLDNESS (ice coldness feeling on her fingers) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Magnetic resonance imaging: abnormal (abnormal) inflammation between vertebrae (C1 to C7 and T2 to T3), stenosis.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient is allergic to latex, fragrance, aromatic soaps, detergents, furr,. fruits like mangoes and kiwi. Also had high ANA levels and considered to be immunocompromised.   This case was linked to MOD-2021-309590.
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: experienced rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (experienced rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (experienced rash). At the time of the report, RASH (experienced rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment medications were not reported.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia, Vaccination complication
Clinical narrative: Experiencing side effects 4 days after the first dose; low grade fever; Chills; headache; Side effects make her tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Experiencing side effects 4 days after the first dose), PYREXIA (low grade fever), CHILLS (Chills), HEADACHE (headache) and FATIGUE (Side effects make her tired) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0582EZ1A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Sep-2021, the patient experienced VACCINATION COMPLICATION (Experiencing side effects 4 days after the first dose), PYREXIA (low grade fever), CHILLS (Chills), HEADACHE (headache) and FATIGUE (Side effects make her tired). At the time of the report, VACCINATION COMPLICATION (Experiencing side effects 4 days after the first dose), PYREXIA (low grade fever), CHILLS (Chills), HEADACHE (headache) and FATIGUE (Side effects make her tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product was not provided by the reporter  Treatment information was not provided   Most recent FOLLOW-UP information incorporated above includes: On 06-Sep-2021: Follow-up information received  included new event (Vaccination complication).
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: felling itching\got itching again, eyes, nostril,  throat, and bottom of the right foot; rush in some spot  on the left arm,; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (felling itching\got itching again, eyes, nostril,  throat, and bottom of the right foot) and RASH (rush in some spot  on the left arm,) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062e21a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure. Concomitant products included METOPROLOL for Blood pressure, PREDNISONE, COLESEVELAM, LISINOPRIL, ESOMEPRAZOLE and VERAPAMIL for an unknown indication.    On 05-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Sep-2021, the patient experienced PRURITUS (felling itching\got itching again, eyes, nostril,  throat, and bottom of the right foot). 06-Sep-2021, the patient experienced RASH (rush in some spot  on the left arm,). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Itching, at an unspecified dose and frequency. At the time of the report, PRURITUS (felling itching\got itching again, eyes, nostril,  throat, and bottom of the right foot) and RASH (rush in some spot  on the left arm,) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Injection site urticaria, Vaccination site erythema
Clinical narrative: Hot spot like hives at injection sight; Bright red spot like hives at injection sight; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE URTICARIA (Hot spot like hives at injection sight) and VACCINATION SITE ERYTHEMA (Bright red spot like hives at injection sight) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE URTICARIA (Hot spot like hives at injection sight) and VACCINATION SITE ERYTHEMA (Bright red spot like hives at injection sight). At the time of the report, INJECTION SITE URTICARIA (Hot spot like hives at injection sight) and VACCINATION SITE ERYTHEMA (Bright red spot like hives at injection sight) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.  No treatment medication were provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: Diagnosed with the shingles; Developed a blistery looking rash on his left leg; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Diagnosed with the shingles) and RASH VESICULAR (Developed a blistery looking rash on his left leg) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Aug-2021, the patient experienced HERPES ZOSTER (Diagnosed with the shingles) and RASH VESICULAR (Developed a blistery looking rash on his left leg). The patient was treated with VALACICLOVIR HYDROCHLORIDE (VALACYCLOVIR HCL) for Antiviral treatment, at a dose of 1 dosage form. At the time of the report, HERPES ZOSTER (Diagnosed with the shingles) and RASH VESICULAR (Developed a blistery looking rash on his left leg) outcome was unknown.            No concomitant medications was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraine; Migraine; This spontaneous case was reported by a consumer and describes the occurrence of the second episode of MIGRAINE (Migraine) and the first episode of MIGRAINE (Migraine) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine (but had not had one in greater than 12 years).    On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced the first episode of MIGRAINE (Migraine). On 01-Sep-2021, the patient experienced the second episode of MIGRAINE (Migraine). At the time of the report, last episode of MIGRAINE (Migraine) had resolved.            Concomitant  and treatment medications were not provided. On 01SEP2021 she experienced another migraine that lasted 3 days
Sex: U
Vaccine: COVID19
Symptoms: Joint swelling, Oedema peripheral
Clinical narrative: legs and feet have ballooned today; not my arm that is swollen, it is my legs and feet; This spontaneous case was reported by a consumer and describes the occurrence of OEDEMA PERIPHERAL (legs and feet have ballooned today) and JOINT SWELLING (not my arm that is swollen, it is my legs and feet) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OEDEMA PERIPHERAL (legs and feet have ballooned today) and JOINT SWELLING (not my arm that is swollen, it is my legs and feet). At the time of the report, OEDEMA PERIPHERAL (legs and feet have ballooned today) and JOINT SWELLING (not my arm that is swollen, it is my legs and feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment medications were reported
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: B-lymphocyte count, B-lymphocyte count decreased
Clinical narrative: B cells low; This spontaneous case was reported by a consumer and describes the occurrence of B-LYMPHOCYTE COUNT DECREASED (B cells low) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced B-LYMPHOCYTE COUNT DECREASED (B cells low). At the time of the report, B-LYMPHOCYTE COUNT DECREASED (B cells low) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, B-lymphocyte count: decreased (Low) Decreased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication information was reported. No treatment medications were provided.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional product use issue
Clinical narrative: Did not get second dose in the time period  stipulated for the second dose; This spontaneous case was reported by a consumer and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Did not get second dose in the time period  stipulated for the second dose) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Sep-2021, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Did not get second dose in the time period  stipulated for the second dose). On 06-Sep-2021, INTENTIONAL PRODUCT USE ISSUE (Did not get second dose in the time period  stipulated for the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.   Treatment information was not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria, Vaccination complication
Clinical narrative: Experienced a topical reaction; The rash/ hives from the first dose stayed localized (lasted 3 months), it was extremly annoying; Itchy; Rash on arm as "COVID Arm", stretched from shoulder to elbow; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION COMPLICATION (Experienced a topical reaction), URTICARIA (The rash/ hives from the first dose stayed localized (lasted 3 months), it was extremly annoying), PRURITUS (Itchy) and RASH (Rash on arm as "COVID Arm", stretched from shoulder to elbow) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder NOS (Autoimmune issue), Myalgia and Hypersensitivity (Hypersensitive to every everything).    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Experienced a topical reaction), URTICARIA (The rash/ hives from the first dose stayed localized (lasted 3 months), it was extremly annoying), PRURITUS (Itchy) and RASH (Rash on arm as "COVID Arm", stretched from shoulder to elbow). The patient was treated with PREDNISONE for Adverse event, at a dose of 5 mg once a day. At the time of the report, VACCINATION COMPLICATION (Experienced a topical reaction), URTICARIA (The rash/ hives from the first dose stayed localized (lasted 3 months), it was extremly annoying), PRURITUS (Itchy) and RASH (Rash on arm as "COVID Arm", stretched from shoulder to elbow) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment medication also include Topical cream.  Patient took second dose on 16 March 2021(batch no 013A21A) and experienced the same side effects. Patient reported that the prescribed topical cream did not work later her Rheumatologist put her on prednisone.   This case was linked to MOD-2021-309819 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Influenza, Myalgia, Oropharyngeal pain
Clinical narrative: flu; sore throat; sick to the stomach; achy body; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (flu), OROPHARYNGEAL PAIN (sore throat), ABDOMINAL DISCOMFORT (sick to the stomach) and MYALGIA (achy body) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for Multiple sclerosis.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (flu), OROPHARYNGEAL PAIN (sore throat), ABDOMINAL DISCOMFORT (sick to the stomach) and MYALGIA (achy body). At the time of the report, INFLUENZA (flu), OROPHARYNGEAL PAIN (sore throat), ABDOMINAL DISCOMFORT (sick to the stomach) and MYALGIA (achy body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: arm  blew up; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm  blew up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included CAPECITABINE (XELODA) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (arm  blew up). At the time of the report, PERIPHERAL SWELLING (arm  blew up) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication was  not reported.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, COVID-19
Clinical narrative: husband's body fight COVID & only have mild symptoms; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (husband's body fight COVID & only have mild symptoms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (husband's body fight COVID & only have mild symptoms). At the time of the report, COVID-19 (husband's body fight COVID & only have mild symptoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103 (High) 103 fever diagnosed with COVID.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.; Sender's Comments: Covid infection following vaccination has a causality assessment of "not applicable" by convention.  The patient's wife indirectly reported that her husband's Covid infection was only mild due to receiving the vaccine. No date of vaccination or onset date of Covid was provided.  Event of Covid-19 captured conservatively as the implication of the report is that the infection occurred after vaccination.  No event of lack of effect captured as it is now known how long after vaccination the infection occurred
Sex: M
Vaccine: COVID19
Symptoms: Bowel movement irregularity, Feeling abnormal
Clinical narrative: hard time going to the restroom; hard time passing a bowel; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (hard time going to the restroom) and BOWEL MOVEMENT IRREGULARITY (hard time passing a bowel) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (hard time going to the restroom) and BOWEL MOVEMENT IRREGULARITY (hard time passing a bowel). At the time of the report, FEELING ABNORMAL (hard time going to the restroom) and BOWEL MOVEMENT IRREGULARITY (hard time passing a bowel) outcome was unknown.            Concomitant product use was not provided by reporter. No treatment information was provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Wrong product administered
Clinical narrative: I felt fatigue / tiredness for one day then it resolved; Administered a third dose of COVID-19 vaccine (PFIZER) instead of flu shot; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (I felt fatigue / tiredness for one day then it resolved) and WRONG PRODUCT ADMINISTERED (Administered a third dose of COVID-19 vaccine (PFIZER) instead of flu shot) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048821A and 046A21A) for COVID-19 vaccination.     No medical history were provided by reporter.  Concomitant products included AMLODIPINE, LEVOTHYROXINE, LOSARTAN, GLIPIZIDE, ROSUVASTATIN, ALLOPURINOL and PREDNISONE for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced WRONG PRODUCT ADMINISTERED (Administered a third dose of COVID-19 vaccine (PFIZER) instead of flu shot). On an unknown date, the patient experienced FATIGUE (I felt fatigue / tiredness for one day then it resolved). On 05-Sep-2021, WRONG PRODUCT ADMINISTERED (Administered a third dose of COVID-19 vaccine (PFIZER) instead of flu shot) had resolved. At the time of the report, FATIGUE (I felt fatigue / tiredness for one day then it resolved) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 05-SEP-2021 the patient went to a pharmacy for a flu vaccine but was accidentally administered a dose of the Pfizer COVID-19 vaccine. No treatment information were provided.
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Intentional dose omission, Uterine haemorrhage
Clinical narrative: After first shot patient had uterine bleeding felt like super heavy period about 3 to 7 days after Moderna vaccine; Felt like super heavy period about 3 to 7 days after Moderna vaccine/ The bleeding episode happened anywhere from three to seven days after the first dose; Intentional Dose omission; This spontaneous case was reported by a pharmacist and describes the occurrence of UTERINE HAEMORRHAGE (After first shot patient had uterine bleeding felt like super heavy period about 3 to 7 days after Moderna vaccine), HEAVY MENSTRUAL BLEEDING (Felt like super heavy period about 3 to 7 days after Moderna vaccine/ The bleeding episode happened anywhere from three to seven days after the first dose) and INTENTIONAL DOSE OMISSION (Intentional Dose omission) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     The patient's past medical history included Uterine abrasion (Patient has a history of uterine abrasions).    On 08-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced UTERINE HAEMORRHAGE (After first shot patient had uterine bleeding felt like super heavy period about 3 to 7 days after Moderna vaccine), HEAVY MENSTRUAL BLEEDING (Felt like super heavy period about 3 to 7 days after Moderna vaccine/ The bleeding episode happened anywhere from three to seven days after the first dose) and INTENTIONAL DOSE OMISSION (Intentional Dose omission). At the time of the report, UTERINE HAEMORRHAGE (After first shot patient had uterine bleeding felt like super heavy period about 3 to 7 days after Moderna vaccine) and HEAVY MENSTRUAL BLEEDING (Felt like super heavy period about 3 to 7 days after Moderna vaccine/ The bleeding episode happened anywhere from three to seven days after the last dose) outcome was unknown and INTENTIONAL DOSE OMISSION (Intentional Dose omission) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  Patient´s history of uterine abrasions is a confounder for the event.
Sex: U
Vaccine: COVID19
Symptoms: Chest discomfort, Cough, Dysphonia, Fatigue, Headache
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (I am having cold symptoms), CHEST DISCOMFORT (Chest tightness), COUGH (Non-productive cough), RHINORRHOEA (Runny nose) and DYSPHONIA (someshoarseness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.No Medical History information was reported.On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (I am having cold symptoms), CHEST DISCOMFORT (Chest tightness), COUGH (Non-productive cough), RHINORRHOEA (Runny nose), DYSPHONIA (someshoarseness), HEADACHE (I also have a headache) and FATIGUE (and fatigue). At the time of the report, NASOPHARYNGITIS (I am having cold symptoms), CHEST DISCOMFORT (Chest tightness), COUGH (Non-productive cough), RHINORRHOEA (Runny nose), DYSPHONIA (someshoarseness), HEADACHE (I also have a headache) and FATIGUE (and fatigue) outcome was unknown.    No  Concomitant medications were provided. No Treatment medications were provided. This case was linked to MOD-2021-310884 (Patient Link). Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Nasopharyngitis, Rhinorrhoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (I am having cold symptoms), CHEST DISCOMFORT (Chest tightness), COUGH (Non-productive cough), RHINORRHOEA (Runny nose) and DYSPHONIA (someshoarseness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.No Medical History information was reported.On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (I am having cold symptoms), CHEST DISCOMFORT (Chest tightness), COUGH (Non-productive cough), RHINORRHOEA (Runny nose), DYSPHONIA (someshoarseness), HEADACHE (I also have a headache) and FATIGUE (and fatigue). At the time of the report, NASOPHARYNGITIS (I am having cold symptoms), CHEST DISCOMFORT (Chest tightness), COUGH (Non-productive cough), RHINORRHOEA (Runny nose), DYSPHONIA (someshoarseness), HEADACHE (I also have a headache) and FATIGUE (and fatigue) outcome was unknown.    No  Concomitant medications were provided. No Treatment medications were provided. This case was linked to MOD-2021-310884 (Patient Link). Reporter did not allow further contact
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Limb discomfort, Nausea, Pyrexia, Vomiting
Clinical narrative: Left arm hurt; Diarrhea; Nausea; Vomiting; Fever; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Left arm hurt), DIARRHOEA (Diarrhea), NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced LIMB DISCOMFORT (Left arm hurt), DIARRHOEA (Diarrhea), NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever). On 09-Apr-2021, LIMB DISCOMFORT (Left arm hurt), DIARRHOEA (Diarrhea), NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by reporter. No treatment details were provided by reporter.   This case was linked to MOD-2021-311111 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Illness, Pyrexia
Clinical narrative: I took the second shot yesterday, now now I'm running a101.4 temperature; Feel this cruddy.; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (I took the second shot yesterday, now now I'm running a101.4 temperature) and ILLNESS (Feel this cruddy.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (I took the second shot yesterday, now now I'm running a101.4 temperature) and ILLNESS (Feel this cruddy.). At the time of the report, PYREXIA (I took the second shot yesterday, now now I'm running a101.4 temperature) and ILLNESS (Feel this cruddy.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.4 (High) High.         No Concomitant medication was reported No treatment Medication was reported
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Unspecified Adverse event.; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Unspecified Adverse event.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Unspecified Adverse event.). At the time of the report, ADVERSE EVENT (Unspecified Adverse event.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.    Reporter did not allow further contact